DAA2436 |
selenium binding protein 1 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
SELENBP1 |
20.8% Decrease DNA Methylation |
|
DAA2387 |
selenium binding protein 1 decreases with age |
Molecular |
dermis |
Human |
SELENBP1 |
15.7% Decrease DNA Methylation |
|
DAA390 |
selenocysteine lyase |
Molecular |
skeletal muscle |
Human |
SCLY |
6.0% Decrease Gene Expression Level |
|
DAA222 |
selenophosphate synthetase 1 |
Molecular |
brain |
Human |
SEPHS1 |
12.0% Increase Gene Expression Level |
|
DAA563 |
selenoprotein P, plasma, 1 |
Molecular |
skeletal muscle |
Human |
SEPP1 |
3.0% Increase Gene Expression Level |
|
DAA1823 |
selenoprotein X 1 |
Molecular |
muscle |
Mouse |
Sepx1 |
3.0% Decrease Gene Expression Level |
|
DAA2092 |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B increases with age |
Molecular |
ovary |
Human |
SEMA4B |
58.0% Increase Gene Expression Level |
|
DAA1456 |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
Molecular |
kidney |
Mouse |
Sema4d |
4.0% Increase Gene Expression Level |
|
DAA220 |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
Molecular |
brain |
Human |
SEMA6A |
8.0% Increase Gene Expression Level |
|
DAA2399 |
semaphorin 3B isoform 2 precursor increases with age |
Molecular |
dermis |
Human |
SEMA3B |
16.1% Increase DNA Methylation |
|
DAA2448 |
semaphorin 3B isoform 2 precursor increases with age |
Molecular |
mesenchymal stem cell |
Human |
SEMA3B |
19.1% Increase DNA Methylation |
|
DAA1273 |
seminal vesicle secretory protein 4 |
Molecular |
brain |
Mouse |
Svs4 |
2642.0% Increase Gene Expression Level |
|
DAA743 |
Sensitivity of HPA axis is impaired |
Physiological |
pituitary gland, adrenal gland, hypothalamus |
Human |
— |
— |
|
DAA743 |
Sensitivity of HPA axis is impaired |
Physiological |
pituitary gland, adrenal gland, hypothalamus |
Human |
— |
— |
|
DAA743 |
Sensitivity of HPA axis is impaired |
Physiological |
pituitary gland, adrenal gland, hypothalamus |
Human |
— |
— |
|
DAA587 |
Septicemia |
Pathological |
blood |
Human |
— |
SeriesMorbidity |
|
DAA1352 |
septin 5 |
Molecular |
hematological system |
Mouse |
Sept5 |
36.0% Increase Gene Expression Level |
|
DAA1580 |
serglycin |
Molecular |
lung |
Mouse |
Srgn |
5.0% Increase Gene Expression Level |
|
DAA1284 |
serine (or cysteine) peptidase inhibitor, clade A, member 3N |
Molecular |
visual apparatus |
Mouse |
Serpina3n |
141.0% Increase Gene Expression Level |
|
DAA1824 |
serine (or cysteine) peptidase inhibitor, clade F, member 1 |
Molecular |
muscle |
Mouse |
Serpinf1 |
8.0% Decrease Gene Expression Level |
|
DAA2402 |
serine (or cysteine) proteinase inhibitor; clade A (alpha-1 antiproteinase; antitrypsin); member 12 decreases with age |
Molecular |
dermis |
Human |
SERPINA12 |
15.2% Decrease DNA Methylation |
|
DAA2451 |
serine (or cysteine) proteinase inhibitor; clade A (alpha-1 antiproteinase; antitrypsin); member 12 increases with age |
Molecular |
mesenchymal stem cell |
Human |
SERPINA12 |
52.7% Increase DNA Methylation |
|
DAA229 |
serine peptidase inhibitor, Kunitz type, 2 |
Molecular |
brain |
Human |
SPINT2 |
3.0% Decrease Gene Expression Level |
|
DAA1728 |
serine protease inhibitor, Kunitz type 2 |
Molecular |
muscle |
Mouse |
Spint2 |
6.0% Increase Gene Expression Level |
|
DAA282 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
Molecular |
kidney |
Human |
SERPINA5 |
11.0% Decrease Gene Expression Level |
|